Norges Bank Takes $40.01 Million Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Norges Bank acquired a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 512,339 shares of the company's stock, valued at approximately $40,009,000. Norges Bank owned about 1.04% of Prestige Consumer Healthcare as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in PBH. Cerity Partners LLC raised its stake in Prestige Consumer Healthcare by 103.9% during the 3rd quarter. Cerity Partners LLC now owns 6,347 shares of the company's stock valued at $458,000 after buying an additional 3,234 shares during the last quarter. BNP Paribas Financial Markets raised its stake in Prestige Consumer Healthcare by 276.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 17,379 shares of the company's stock valued at $1,253,000 after buying an additional 12,759 shares during the last quarter. HighTower Advisors LLC raised its stake in Prestige Consumer Healthcare by 4.9% during the 3rd quarter. HighTower Advisors LLC now owns 16,708 shares of the company's stock valued at $1,215,000 after buying an additional 774 shares during the last quarter. Stifel Financial Corp raised its stake in Prestige Consumer Healthcare by 13.7% during the 3rd quarter. Stifel Financial Corp now owns 19,299 shares of the company's stock valued at $1,391,000 after buying an additional 2,322 shares during the last quarter. Finally, Wellington Management Group LLP purchased a new stake in Prestige Consumer Healthcare during the 3rd quarter valued at $6,342,000. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock traded down $2.87 during mid-day trading on Thursday, hitting $80.32. The stock had a trading volume of 49,888 shares, compared to its average volume of 350,208. The firm has a market capitalization of $3.98 billion, a P/E ratio of 18.81, a P/E/G ratio of 2.69 and a beta of 0.47. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. The firm's 50 day moving average is $84.33 and its 200 day moving average is $79.69. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on PBH shares. Canaccord Genuity Group boosted their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Oppenheimer boosted their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a research report on Thursday, February 13th. Raymond James raised shares of Prestige Consumer Healthcare to a "moderate buy" rating in a research report on Thursday, December 19th. Royal Bank of Canada boosted their price objective on shares of Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a "sector perform" rating in a research report on Friday, March 21st. Finally, StockNews.com downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Tuesday. Four analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $93.33.

Insider Buying and Selling at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the transaction, the senior vice president now owns 17,157 shares of the company's stock, valued at $1,544,130. This represents a 8.91 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.60% of the company's stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.